Bruker Corporation announced on February 24, 2025, that its Spatial Biology division would unveil significant advancements at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. These innovations underscore Bruker’s commitment to leading spatial biology.
Key announcements include the CosMx Whole Transcriptome Panel (WTX) for the CosMx Spatial Molecular Imager (SMI), capable of detecting over 18,000 RNA transcripts at single-cell resolution. Orders for the Human WTX panel will commence in April, with commercial shipments expected in summer 2025.
Other advancements include an expanded GeoMx DSP protein panel to spatially profile 1000 proteins, the new PaintScape™ platform for direct visualization of the 3D genome, and enhancements to the CellScape platform with the PowerOMX™ Engine for improved throughput and data quality. Bruker also plans to launch the Sapphire Spatial Program for premium customer support and extend its collaboration with Weill Cornell Medicine on the Spatial Atlas of Human Anatomy initiative.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.